• Depot
  • Watchlist
  • Glocke
  • Handeln

    • Relief Therapeutics Holding News

    1,30 CHF +4,00% +0,05 CHF
    In : 1,3293 € | 26.04.24 17:03:22 SIX Swiss Exchange aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3EFB5
    ISIN: CH1251125998
    US-Symbol: RLFTF
    Typ: Aktie

    Relief Therapeutics Holding News

    03.05.23 - DGAP
    Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares
    Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares 03.05.2023 / 07:00 ...
    01.05.23 - DGAP
    Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA™ Commercial Launch Progressing Ahead of Schedule
    Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA™ Commercial Launch Progressing Ahead of ...
    28.04.23 - DGAP
    Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders
    Relief Therapeutics Holding SA / Key word(s): AGMEGM Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders 28.04.2023 / 19:00 CET/CEST
    17.04.23 - DGAP
    Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
    Relief Therapeutics Holding SA / Key word(s): Research Update Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-...
    14.04.23 - DGAP
    Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update
    Relief Therapeutics Holding SA / Key word(s): Annual Results Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update 14-Apr-2023 / 07:00 ...
    05.04.23 - DGAP
    Relief Therapeutics Announces Executive Leadership Team Change
    Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Announces Executive Leadership Team Change 05-Apr-2023 / 07:00 CET/CEST Release of an ad hoc ...
    04.04.23 - DGAP
    Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
    Relief Therapeutics Holding SA / Key word(s): AGMEGM Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders 04-Apr-2023 / 07:00 CET/CEST ...
    03.04.23 - DGAP
    Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
    Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Appoints World-​Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory ...
    22.03.23 - DGAP
    Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
    Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented ...
    17.03.23 - DGAP
    Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting
    Relief Therapeutics Holding SA / Key word(s): Study results Relief Therapeutics to Present Pre-​Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society ...
    16.03.23 - DGAP
    Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe
    Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe 16.03.2023 / 07:00 CET/CEST
    15.03.23 - DGAP
    Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™ 
    Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™  15-March-2023 / 07:00 CET/CEST ...
    28.02.23 - DGAP
    Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars
    Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars ...
    14.02.23 - DGAP
    Relief Therapeutics Announces Enrollment of First Three Patients in Proof-of-Concept Clinical Trial of RLF-TD011 for the Treatment of Epidermolysis Bullosa
    Relief Therapeutics Holding SA / Key word(s): Study Relief Therapeutics Announces Enrollment of First Three Patients in Proof-​of-Concept Clinical Trial of RLF-TD011 for the ...
    08.02.23 - DGAP
    Relief Therapeutics Provides an Update on its Financing Strategy
    Relief Therapeutics Holding SA / Key word(s): Financing Relief Therapeutics Provides an Update on its Financing Strategy 08-Feb-2023 / 07:00 CET/CEST Release of an ad hoc ...
    17.01.23 - DGAP
    Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom
    Relief Therapeutics Holding SA / Key word(s): Study Relief Therapeutics Announces IRB Approval of Investigator-​Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for ...
    27.12.22 - DGAP
    Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission
    Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form F-1 with the U.S. Securities and ...
    27.12.22 - DGAP
    Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle Disorders
    Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle ...
    20.12.22 - DGAP
    Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements
    Relief Therapeutics Holding SA / Key word(s): Legal Matter Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements 20-...
    14.12.22 - DGAP
    Relief Therapeutics to Participate in January Investor Meetings
    Relief Therapeutics Holding SA / Key word(s): Conference Relief Therapeutics to Participate in January Investor Meetings 14.12.2022 / 07:00 CET/CEST

    Newssuche

    Videos

    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »